Claes Mörlin

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

Lennart Hansson, Lars Lindholm, Leo Niskanen et al. · The Lancet · 1999 · 2K citations

Hypertension, Cardiovascular Disease, Antihypertensive Agents +10

A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial.

Ulrika Gillespie, Anna Alassaad, Dan Henrohn et al. · PubMed · 2009 · 572 citations

Metabolic effects of diltiazem and atenolol: results from a randomized, double-blind study with parallel groups

Thomas Pollare, Hans Lithell, Claes Mörlin et al. · Journal of Hypertension · 1989 · 180 citations

The HOPE (Heart Outcomes Prevention Evaluation) Study: The design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events

F Mindlen, Roberto Nordaby, M I Soto Ruiz et al. · Queensland's institutional digital repository (The University of Queensland) · 1996 · 154 citations

Non-pharmacological Intervention, Preventive Medicine, Cardiovascular Disease +10

Effects of Pharmacists' Interventions on Appropriateness of Prescribing and Evaluation of the Instruments' (MAI, STOPP and STARTs') Ability to Predict Hospitalization–Analyses from a Randomized Controlled Trial

Ulrika Gillespie, Anna Alassaad, Margareta Hammarlund‐Udenaes et al. · PLoS ONE · 2013 · 124 citations · Full text